These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22762718)

  • 1. In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
    Reed SD; Li Y; Dunlap ME; Kraus WE; Samsa GP; Schulman KA; Zile MR; Whellan DJ
    Am J Cardiol; 2012 Oct; 110(8):1150-5. PubMed ID: 22762718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.
    Unroe KT; Greiner MA; Hernandez AF; Whellan DJ; Kaul P; Schulman KA; Peterson ED; Curtis LH
    Arch Intern Med; 2011 Feb; 171(3):196-203. PubMed ID: 20937916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource use in the last 6 months of life among patients with heart failure in Canada.
    Kaul P; McAlister FA; Ezekowitz JA; Bakal JA; Curtis LH; Quan H; Knudtson ML; Armstrong PW
    Arch Intern Med; 2011 Feb; 171(3):211-7. PubMed ID: 20937918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patients with heart failure in the last year of their life: the primary care perspective].
    D'Ambrosio G; Filippi A; Battaggia A; De Maria R; Cricelli C
    G Ital Cardiol (Rome); 2014 Oct; 15(10):569-76. PubMed ID: 25424021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.
    Hollingworth W; Biswas M; Maishman RL; Dayer MJ; McDonagh T; Purdy S; Reeves BC; Rogers CA; Williams R; Pufulete M
    Int J Cardiol; 2016 Dec; 224():132-138. PubMed ID: 27648982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.
    Reed SD; Whellan DJ; Li Y; Friedman JY; Ellis SJ; Piña IL; Settles SJ; Davidson-Ray L; Johnson JL; Cooper LS; O'Connor CM; Schulman KA;
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):374-81. PubMed ID: 20551371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.
    Li Y; Levy WC; Neilson MP; Ellis SJ; Whellan DJ; Schulman KA; O'Connor CM; Reed SD
    J Card Fail; 2014 Aug; 20(8):541-7. PubMed ID: 24887579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).
    Thorn JC; Turner EL; Hounsome L; Walsh E; Down L; Verne J; Donovan JL; Neal DE; Hamdy FC; Martin RM; Noble SM;
    BMJ Open; 2016 Apr; 6(4):e011063. PubMed ID: 27130167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure).
    Rao MP; Al-Khatib SM; Pokorney SD; She L; Romanov A; Nicolau JC; Lee KL; Carson P; Selzman CH; Stepinska J; Cleland JG; Tungsubutra W; Desvigne-Nickens PM; Sueta CA; Siepe M; Lang I; Feldman AM; Yii M; Rouleau JL; Velazquez EJ;
    Circulation; 2017 Mar; 135(12):1136-1144. PubMed ID: 28154006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
    Pokorney SD; Al-Khatib SM; Sun JL; Schulte P; O'Connor CM; Teerlink JR; Armstrong PW; Ezekowitz JA; Starling RC; Voors AA; Velazquez EJ; Hernandez AF; Mentz RJ
    Eur J Heart Fail; 2018 Mar; 20(3):525-532. PubMed ID: 29266564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: A descriptive study using registry data.
    van der Plas AG; Oosterveld-Vlug MG; Pasman HR; Onwuteaka-Philipsen BD
    Palliat Med; 2017 Apr; 31(4):338-345. PubMed ID: 28056634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION.
    Reed SD; Li Y; Ellis SJ; Isitt JJ; Cheng S; Schulman KA; Whellan DJ
    J Card Fail; 2012 Oct; 18(10):784-91. PubMed ID: 23040114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score.
    Lupón J; Cediel G; Moliner P; de Antonio M; Domingo M; Zamora E; Núñez J; González B; Santiago-Vacas E; Santesmases J; Troya MI; Díez-Quevedo C; Boldó M; Barallat J; Bayes-Genis A
    Int J Cardiol; 2019 Oct; 293():148-152. PubMed ID: 31155333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    Adv Ther; 2017 Jan; 34(1):261-276. PubMed ID: 27933568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
    Reed SD; Li Y; Leal J; Radican L; Adler AI; Alfredsson J; Buse JB; Green JB; Kaufman KD; Riefflin A; Van de Werf F; Peterson ED; Gray AM; Holman RR;
    Diabetes Obes Metab; 2018 Jul; 20(7):1732-1739. PubMed ID: 29573215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
    Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
    J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA.
    O'Day K; Levy WC; Johnson M; Jacobson AF
    Appl Health Econ Health Policy; 2016 Jun; 14(3):361-73. PubMed ID: 26975999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.